Speech-Language Pathologists in Stewartstown, PA Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Mrs. Sherri J Linthicum, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 Berkshire Ln, Stewartstown, PA 17363 Phone: 717-993-3239

Ashley Braquel Hushon, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15354 Leib School Rd, Stewartstown, PA 17363 Phone: 717-683-8422

Jordyn Koveleski Gorman, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4052 Barwood Ln, Stewartstown, PA 17363 Phone: 717-824-5708

Precise Communication Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Bailey Dr # 26, Stewartstown, PA 17363 Phone: 443-858-2482

News Archive

HealthGrades honors Eastern Long Island Hospital with Outstanding Patient Experience Award

Eastern Long Island Hospital (ELIH) is among the top 15 percent in the nation for patient experience based on an analysis of patient surveys from 3,775 hospitals across the country by HealthGrades, the leading independent healthcare ratings organization. By placing in the top 15 percent, ELIH received the 2010/2011 HealthGrades Outstanding Patient Experience Award(TM).

IV iron dextran alternative to oral iron for anemia in nondialysis CKD

Treatment with intravenous low-molecular-weight iron dextran seems to be an effective alternative for patients with nondialysis chronic kidney disease who remain anemic despite receiving oral iron and erythropoiesis-stimulating agents.

Mobile phone use should be banned in cars altogether

Hands-free mobile phones have failed to make the roads safer according to a University of Sussex psychologist.

Novel drug delivery technique uses graphene to deliver two anticancer drugs sequentially to cancer cells

An international team of researchers has developed a drug delivery technique that utilizes graphene strips as "flying carpets" to deliver two anticancer drugs sequentially to cancer cells, with each drug targeting the distinct part of the cell where it will be most effective. The technique was found to perform better than either drug in isolation when tested in a mouse model targeting a human lung cancer tumor.

Read more Medical News

› Verified 8 days ago